A large retrospective analysis of pemetrexed (PEM) activity in patients (pts) with ALK-positive (ALK+) non-small cell lung cancer (NSCLC) prior to crizotinib (CRIZ) treatment Meeting Abstract


Authors: Scagliotti, G.; Kim, D. W.; Shaw, A. T.; Ou, S. I.; Riely, G. J.; Gettinger, S.; Besse, B.; Wilner, K.; Tang, Y.; Bartlett, C. H.
Abstract Title: A large retrospective analysis of pemetrexed (PEM) activity in patients (pts) with ALK-positive (ALK+) non-small cell lung cancer (NSCLC) prior to crizotinib (CRIZ) treatment
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix415
Language: English
ACCESSION: WOS:000309409002202
PROVIDER: wos
PUBMED: 23012731
DOI: 10.1093/annonc/mds409
Notes: Meeting Abstract: 1267P -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    605 Riely